Moustafa Abdou: Tumor Lysis Syndrome Is a Preventable but Life-Threatening Oncologic Emergency
Moustafa Abdou, Author and Founder of AskHematologist.com, shared a post on LinkedIn:
”Tumor Lysis Syndrome (TLS): Preventable, Yet Potentially Fatal
Tumor Lysis Syndrome remains one of the most critical oncologic emergencies in clinical practice. Rapid tumor cell breakdown can lead to severe metabolic disturbances, including hyperkalemia, hyperuricemia, and acute kidney injury, with potentially life-threatening consequences.
Importantly, TLS is no longer confined to high-grade lymphomas and acute leukemias. With the increasing use of targeted therapies, it is now recognized across a broader spectrum of malignancies.
Early risk stratification, close monitoring, and timely intervention, including hydration and appropriate use of agents such as rasburicase, are essential to improving patient outcomes.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines